相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Potential Vascular Mechanisms of Ramipril Induced Increases in Walking Ability in Patients With Intermittent Claudication
Anna A. Ahimastos et al.
CIRCULATION RESEARCH (2014)
Association Between Statin Medications and Mortality, Major Adverse Cardiovascular Event, and Amputation-Free Survival in Patients With Critical Limb Ischemia
Gregory G. Westin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Quality of care among patients undergoing lower extremity revascularization
David P. Slovut et al.
VASCULAR MEDICINE (2014)
Adherence to Guideline-Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial Disease
Ehrin J. Armstrong et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Effect of Ramipril on Walking Times and Quality of Life Among Patients With Peripheral Artery Disease and Intermittent Claudication A Randomized Controlled Trial
Anna A. Ahimastos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Optimal medical therapy predicts amputation-free survival in chronic critical limb ischemia
Jayer Chung et al.
JOURNAL OF VASCULAR SURGERY (2013)
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
F. Gerald R. Fowkes et al.
LANCET (2013)
The global pandemic of peripheral artery disease
Alan T. Hirsch et al.
LANCET (2013)
Gender-related variation in the clinical presentation and outcomes of critical limb ischemia
Caroline E. McCoach et al.
VASCULAR MEDICINE (2013)
Secondary Prevention and Mortality in Peripheral Artery Disease National Health and Nutrition Examination Study, 1999 to 2004
Reena L. Pande et al.
CIRCULATION (2011)
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 Performance Measures for Adults With Peripheral Artery Disease A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease)
Jeffrey W. Olin et al.
CIRCULATION (2010)
Vascular Hospitalization Rates and Costs in Patients With Peripheral Artery Disease in the United States
Elizabeth M. Mahoney et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2010)
Endothelial Dysfunction - The First Step Toward Coronary Arteriosclerosis
Paul M. Vanhoutte
CIRCULATION JOURNAL (2009)
Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry
Patrice P. Cacoub et al.
ATHEROSCLEROSIS (2008)
Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis
Ping Li et al.
HYPERTENSION (2008)
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis
Gianpaolo Reboldi et al.
JOURNAL OF HYPERTENSION (2008)
Long-term prognosis of patients with peripheral arterial disease - A comparison in patients with coronary artery disease
Gijs M. J. M. Welten et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Telmisartan, ramipril, or both in patients at high risk for vascular events
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases
Lesley H. Curtis et al.
MEDICAL CARE (2007)
Epidemiology, classification, and modifiable risk factors of peripheral arterial disease
Nicolas W. Shammas
VASCULAR HEALTH AND RISK MANAGEMENT (2007)
Inter-society consensus for the management of peripheral arterial disease (TASC II)
L. Norgren et al.
JOURNAL OF VASCULAR SURGERY (2007)
Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease
HHH Feringa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic) - A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery,* Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease)
AT Hirsch et al.
CIRCULATION (2006)
ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (Lower extremity, renal, mesenteric, and abdominal aortic): Executive summary
AT Hirsch et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Long-term effects of ramipril on cardiovascular events and on diabetes - Results of the HOPE study extension
J Bosch et al.
CIRCULATION (2005)
Adjusted survival curves with inverse probability weights
SR Cole et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2004)
Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease
J Ostergren et al.
EUROPEAN HEART JOURNAL (2004)
The potential role of angiotensin-converting enzyme inhibition in peripheral arterial disease
AT Hirsch et al.
VASCULAR MEDICINE (2003)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Angiotensin-converting enzyme inhibition improves defective angiogenesis in the ischemic limb of spontaneously hypertensive rats
S Takeshita et al.
CARDIOVASCULAR RESEARCH (2001)
Peripheral arterial disease detection, awareness, and treatment in primary care
AT Hirsch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
分享论文
